Virica Biotech Inc. (“Virica”), a leading developer of solutions for scaling of viral medicines, will be featured in a live webinar to be held on Monday, November 14, 2022, at 2:30pm EST. This webinar will focus on process intensification in the manufacturing of adeno associated virus (AAV) vectors.

Tune into this free webinar to learn about:

  • AAV biology and its use in cell and gene therapies
  • State-of-the-art production of cell and gene therapies
  • Current process intensification methods: cell line and vector engineering, media optimization, and bioreactor design to increase yields
  • New strategies to properly attenuate anti-viral defences in the production system: viral sensitizer technology.

Read the full press release here.